Cisatracurium Retards Cell Migration and Invasion Upon Upregulation of p53 and Inhibits the Aggressiveness of Colorectal Cancer

Colorectal cancer (CRC) is reported to be the third and fourth, most diagnosed and cause of cancer associated deaths respectively. In 2012 for instance, about 1.4 million new cases were reported, and approximately 700,000 deaths recorded. Survival from CRC is dependent on the stage at which it is di...

Full description

Bibliographic Details
Main Authors: Iddrisu B. Yabasin, Jaceline G. P. Sanches, Mohammed M. Ibrahim, Jin Huidan, Walana Williams, Zhi-Li Lu, Qingping Wen
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-07-01
Series:Frontiers in Physiology
Subjects:
p53
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2018.00941/full
id doaj-9fba0e3f58a9441dbae63cc2f01728d3
record_format Article
spelling doaj-9fba0e3f58a9441dbae63cc2f01728d32020-11-24T21:42:49ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2018-07-01910.3389/fphys.2018.00941378176Cisatracurium Retards Cell Migration and Invasion Upon Upregulation of p53 and Inhibits the Aggressiveness of Colorectal CancerIddrisu B. Yabasin0Jaceline G. P. Sanches1Mohammed M. Ibrahim2Jin Huidan3Walana Williams4Zhi-Li Lu5Qingping Wen6Department of Anesthesiology, First Affiliated Hospital of Dalian Medical University, Dalian, ChinaDepartment of Pathology and Forensics, Dalian Medical University, Dalian, ChinaDepartment of Pathology and Forensics, Dalian Medical University, Dalian, ChinaDepartment of Anesthesiology, First Affiliated Hospital of Dalian Medical University, Dalian, ChinaDepartment of Microbiology and Immunology, Dalian Medical University, Dalian, ChinaDepartment of Ophthalmology, First Affiliated Hospital of Dalian Medical University, Dalian, ChinaDepartment of Anesthesiology, First Affiliated Hospital of Dalian Medical University, Dalian, ChinaColorectal cancer (CRC) is reported to be the third and fourth, most diagnosed and cause of cancer associated deaths respectively. In 2012 for instance, about 1.4 million new cases were reported, and approximately 700,000 deaths recorded. Survival from CRC is dependent on the stage at which it is diagnosed coupled with appropriate surgical and medical intervention. Cisatracurium is widely used for skeletal muscle relaxation during abdominal surgeries, including bowel and colon surgeries. Recent studies reported that cisatracurium inhibits progression of human cancer cells, however, the mechanisms leading to the inhibition are yet to be completely understood. To elucidate mechanisms resulting particularly in tumor cell growth and metastasis, we developed ex vivo and in in vivo xenograft models of CRC. Cisatracurium caused upregulation of p53 and its down-stream genes and proteins known to regulate proliferation and metastasis in vitro and in vivo. Genomic analyses of CRC following cisatracurium treatment revealed moderate to high DNA damage, while functional analyses demonstrated significant tumor cells growth regression, as well as repression of migration and invasion. Importantly, cisatracurium increased E-Cadherin and CALD-1 but decreased SNAI-1 and SLUG levels in vitro and in vivo. Together, the findings demonstrate that elevation of p53 upon cisatracurium-induced genomic injury, represent a potential mechanism by which cisatracurium result in the suppression of CRC progression and metastasis.https://www.frontiersin.org/article/10.3389/fphys.2018.00941/fullcisatracuriummigrationinvasioncolorectal cancerp53
collection DOAJ
language English
format Article
sources DOAJ
author Iddrisu B. Yabasin
Jaceline G. P. Sanches
Mohammed M. Ibrahim
Jin Huidan
Walana Williams
Zhi-Li Lu
Qingping Wen
spellingShingle Iddrisu B. Yabasin
Jaceline G. P. Sanches
Mohammed M. Ibrahim
Jin Huidan
Walana Williams
Zhi-Li Lu
Qingping Wen
Cisatracurium Retards Cell Migration and Invasion Upon Upregulation of p53 and Inhibits the Aggressiveness of Colorectal Cancer
Frontiers in Physiology
cisatracurium
migration
invasion
colorectal cancer
p53
author_facet Iddrisu B. Yabasin
Jaceline G. P. Sanches
Mohammed M. Ibrahim
Jin Huidan
Walana Williams
Zhi-Li Lu
Qingping Wen
author_sort Iddrisu B. Yabasin
title Cisatracurium Retards Cell Migration and Invasion Upon Upregulation of p53 and Inhibits the Aggressiveness of Colorectal Cancer
title_short Cisatracurium Retards Cell Migration and Invasion Upon Upregulation of p53 and Inhibits the Aggressiveness of Colorectal Cancer
title_full Cisatracurium Retards Cell Migration and Invasion Upon Upregulation of p53 and Inhibits the Aggressiveness of Colorectal Cancer
title_fullStr Cisatracurium Retards Cell Migration and Invasion Upon Upregulation of p53 and Inhibits the Aggressiveness of Colorectal Cancer
title_full_unstemmed Cisatracurium Retards Cell Migration and Invasion Upon Upregulation of p53 and Inhibits the Aggressiveness of Colorectal Cancer
title_sort cisatracurium retards cell migration and invasion upon upregulation of p53 and inhibits the aggressiveness of colorectal cancer
publisher Frontiers Media S.A.
series Frontiers in Physiology
issn 1664-042X
publishDate 2018-07-01
description Colorectal cancer (CRC) is reported to be the third and fourth, most diagnosed and cause of cancer associated deaths respectively. In 2012 for instance, about 1.4 million new cases were reported, and approximately 700,000 deaths recorded. Survival from CRC is dependent on the stage at which it is diagnosed coupled with appropriate surgical and medical intervention. Cisatracurium is widely used for skeletal muscle relaxation during abdominal surgeries, including bowel and colon surgeries. Recent studies reported that cisatracurium inhibits progression of human cancer cells, however, the mechanisms leading to the inhibition are yet to be completely understood. To elucidate mechanisms resulting particularly in tumor cell growth and metastasis, we developed ex vivo and in in vivo xenograft models of CRC. Cisatracurium caused upregulation of p53 and its down-stream genes and proteins known to regulate proliferation and metastasis in vitro and in vivo. Genomic analyses of CRC following cisatracurium treatment revealed moderate to high DNA damage, while functional analyses demonstrated significant tumor cells growth regression, as well as repression of migration and invasion. Importantly, cisatracurium increased E-Cadherin and CALD-1 but decreased SNAI-1 and SLUG levels in vitro and in vivo. Together, the findings demonstrate that elevation of p53 upon cisatracurium-induced genomic injury, represent a potential mechanism by which cisatracurium result in the suppression of CRC progression and metastasis.
topic cisatracurium
migration
invasion
colorectal cancer
p53
url https://www.frontiersin.org/article/10.3389/fphys.2018.00941/full
work_keys_str_mv AT iddrisubyabasin cisatracuriumretardscellmigrationandinvasionuponupregulationofp53andinhibitstheaggressivenessofcolorectalcancer
AT jacelinegpsanches cisatracuriumretardscellmigrationandinvasionuponupregulationofp53andinhibitstheaggressivenessofcolorectalcancer
AT mohammedmibrahim cisatracuriumretardscellmigrationandinvasionuponupregulationofp53andinhibitstheaggressivenessofcolorectalcancer
AT jinhuidan cisatracuriumretardscellmigrationandinvasionuponupregulationofp53andinhibitstheaggressivenessofcolorectalcancer
AT walanawilliams cisatracuriumretardscellmigrationandinvasionuponupregulationofp53andinhibitstheaggressivenessofcolorectalcancer
AT zhililu cisatracuriumretardscellmigrationandinvasionuponupregulationofp53andinhibitstheaggressivenessofcolorectalcancer
AT qingpingwen cisatracuriumretardscellmigrationandinvasionuponupregulationofp53andinhibitstheaggressivenessofcolorectalcancer
_version_ 1725916903946321920